Discovering Knowledge

Innovating tomorrow’s
medicine

Explore Now

We believe, in the omics and AI era, a platform’s durable advantage is deeply rooted in the wet lab.
—Our numerous patented wet-lab innovations engineer superior data quality, sensitivity, and reproducibility—creating proprietary data that enable AI models to perform meaningfully better than models trained on standardized data from commercial platforms, and to remain defensible at scale.

We believe —
Our durable advantage comes from proprietary wet-lab procedures and pipelines that generate ultra-high-quality data inaccessible to others—enabling purpose-built AI that materially outperforms generic models trained on standardized commercial data.
— This organic combination keeps us defensible at scale.

Liquid & Tissue Biopsy | Disease Screening

Complete360®

Trademark Registration No. 7,778,754

Patent Issued: 12,540,946 B2

Patent Pending: PCT/US24/62398; 63/643,536; 63/684,367; 63/686,953; 19/299,807; 19/198,934; 63/815,399; 19/309,422; 63/898,368; 63/898,378; 63/963,253; CN117597583; EP4308918; WO/2022/198071

Valid-NEO®

Trademark Registration NOA Serial #: 97,416,492

Patent Issued: 11,977,057 B2; 12,473,587 B2

Patent Pending: 3607065; 17/132,121; 63/038,816; 3607064; US2021-0389280; WO2018/186947; WO2021/252990; CN115698033; 40080610; 4165059; 40087334; ZL201880037683; ZL201880037641

Scientists, Engineers, and Builders of the Proteome Era

Our team brings together leading scientists, engineers, and innovators dedicated to advancing proteomics and multi-omcis measurement technologies, building the platforms and infrastructure that enable large-scale molecular discovery and the next generation of precision medicine.

The Science Behind Complete Omics

Complete Omics develops advanced proteomics and multi-omics technologies to systematically measure the human proteome at unprecedented depth and scale, transforming complex biological signals from plasma and tissues into actionable insights for precision medicine and disease detection.